{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:53:50Z","timestamp":1791273230684,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurogenetics"],"DOI":"10.1007\/s10048-026-00949-5","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:30:50Z","timestamp":1791271850000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic findings in a Turkish clinical cohort with hereditary Parkinson\u2019s disease"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-7707-4871","authenticated-orcid":false,"given":"Dilek","family":"Ozata Aksoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf","family":"Tunca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Riza","family":"Sonkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"Torun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osman","family":"Korucu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"issue":"S5","key":"949_CR1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s00415-008-5004-3","volume":"255","author":"G Alves","year":"2008","unstructured":"Alves G, Forsaa EB, Pedersen KF, Dreetz Gjerstad M, Larsen JP (2008) Epidemiology of Parkinson\u2019s disease. J Neurol 255(S5):18\u201332. https:\/\/doi.org\/10.1007\/s00415-008-5004-3","journal-title":"J Neurol"},{"key":"949_CR2","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/mdc3.13523","volume":"9","author":"R Mehanna","year":"2022","unstructured":"Mehanna R, Smilowska K, Fleisher J et al (2022) Age cutoff for early-onset Parkinson\u2019s disease: recommendations from the international Parkinson and movement disorder society task force on early onset Parkinson\u2019s disease. Mov Disord Clin Pract 9:869\u2013878. https:\/\/doi.org\/10.1002\/mdc3.13523","journal-title":"Mov Disord Clin Pract"},{"key":"949_CR3","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddp012","author":"S Lesage","year":"2009","unstructured":"Lesage S, Brice A (2009) Parkinson\u2019s disease: from monogenic forms to genetic susceptibility factors. Hum Mol Genet. https:\/\/doi.org\/10.1093\/hmg\/ddp012","journal-title":"Hum Mol Genet"},{"key":"949_CR4","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/ane.12563","volume":"134","author":"K Kalinderi","year":"2016","unstructured":"Kalinderi K, Bostantjopoulou S, Fidani L (2016) The genetic background of Parkinson\u2019s disease: current progress and future prospects. Acta Neurol Scand 134:314\u2013326. https:\/\/doi.org\/10.1111\/ane.12563","journal-title":"Acta Neurol Scand"},{"key":"949_CR5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1055\/s-0037-1601567","volume":"37","author":"C Kim","year":"2017","unstructured":"Kim C, Alcalay R (2017) Genetic forms of Parkinson\u2019s disease. Semin Neurol 37:135\u2013146. https:\/\/doi.org\/10.1055\/s-0037-1601567","journal-title":"Semin Neurol"},{"key":"949_CR6","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/mds.27352","volume":"33","author":"M Kasten","year":"2018","unstructured":"Kasten M, Hartmann C, Hampf J et al (2018) Genotype-phenotype relations for the Parkinson\u2019s disease genes Parkin, PINK1, DJ1: MDSGene systematic review. Mov Disord 33:730\u2013741. https:\/\/doi.org\/10.1002\/mds.27352","journal-title":"Mov Disord"},{"issue":"S1","key":"949_CR7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/jnc.13593","volume":"139","author":"DG Hernandez","year":"2016","unstructured":"Hernandez DG, Reed X, Singleton AB (2016) Genetics in Parkinson disease: Mendelian versus non-Mendelian inheritance. J Neurochem 139(S1):59\u201374. https:\/\/doi.org\/10.1111\/jnc.13593","journal-title":"J Neurochem"},{"key":"949_CR8","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E et al (1997) Mutation in the \u03b1-synuclein gene identified in families with Parkinson\u2019s disease. Science 276:2045\u20132047. https:\/\/doi.org\/10.1126\/science.276.5321.2045","journal-title":"Science"},{"key":"949_CR9","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.mcp.2016.11.001","volume":"30","author":"CM Lill","year":"2016","unstructured":"Lill CM (2016) Genetics of Parkinson\u2019s disease. Mol Cell Probes 30:386\u2013396. https:\/\/doi.org\/10.1016\/j.mcp.2016.11.001","journal-title":"Mol Cell Probes"},{"key":"949_CR10","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/ng.3043","volume":"46","author":"MA Nalls","year":"2014","unstructured":"Nalls MA, Pankratz N, Lill CM et al (2014) Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson\u2019s disease. Nat Genet 46:989\u2013993. https:\/\/doi.org\/10.1038\/ng.3043","journal-title":"Nat Genet"},{"key":"949_CR11","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. Lancet 386:896\u2013912. https:\/\/doi.org\/10.1016\/S0140-6736(14)61393-3","journal-title":"Lancet"},{"key":"949_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.parkreldis.2021.10.024","volume":"93","author":"I Emekli","year":"2021","unstructured":"Emekli I, Tepge\u00e7 F, Samanc\u0131 B et al (2021) Clinical and molecular genetic findings of hereditary Parkinson\u2019s patients from Turkey. Parkinsonism Relat Disord 93:35\u201339. https:\/\/doi.org\/10.1016\/j.parkreldis.2021.10.024","journal-title":"Parkinsonism Relat Disord"},{"key":"949_CR13","unstructured":"G\u00fcl T (2024) The complex molecular landscape of Parkinson\u2019s disease in Turkey: Genotype-phenotype correlations in a potentially genetic cohort. Dissertation, Koc University"},{"key":"949_CR14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.55697\/tnd.2025.163","volume":"31","author":"TS Turk","year":"2025","unstructured":"Turk TS, Acarer A, Durmaz A et al (2025) Investigation of mutations in early-onset Parkinson\u2019s disease through next-generation sequencing analysis. Turk J Neurol 31:109\u2013117. https:\/\/doi.org\/10.55697\/tnd.2025.163","journal-title":"Turk J Neurol"},{"key":"949_CR15","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00439-020-02199-3","volume":"139","author":"PD Stenson","year":"2020","unstructured":"Stenson PD, Mort M, Ball EV et al (2020) The Human Gene Mutation Database (HGMD\u00ae): optimizing its use in a clinical diagnostic or research setting. Hum Genet 139:1197\u20131207. https:\/\/doi.org\/10.1007\/s00439-020-02199-3","journal-title":"Hum Genet"},{"issue":"D1","key":"949_CR16","doi-asserted-by":"publisher","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","volume":"46","author":"MJ Landrum","year":"2018","unstructured":"Landrum MJ, Lee JM, Benson M et al (2018) ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res 46(D1):D1062\u2013D1067. https:\/\/doi.org\/10.1093\/nar\/gkx1153","journal-title":"Nucleic Acids Res"},{"key":"949_CR17","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","volume":"99","author":"NM Ioannidis","year":"2016","unstructured":"Ioannidis NM, Rothstein JH, Pejaver V et al (2016) REVEL: an ensemble method for predicting the pathogenicity of rare missense variants. Am J Hum Genet 99:877\u2013885. https:\/\/doi.org\/10.1016\/j.ajhg.2016.08.016","journal-title":"Am J Hum Genet"},{"key":"949_CR18","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/nprot.2009.86","volume":"4","author":"P Kumar","year":"2009","unstructured":"Kumar P, Henikoff S, Ng PC (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4:1073\u20131081. https:\/\/doi.org\/10.1038\/nprot.2009.86","journal-title":"Nat Protoc"},{"key":"949_CR19","doi-asserted-by":"publisher","unstructured":"Adzhubei I, Jordan DM, Sunyaev SR (2013) Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet. https:\/\/doi.org\/10.1002\/0471142905.hg0720s76","DOI":"10.1002\/0471142905.hg0720s76"},{"issue":"D1","key":"949_CR20","doi-asserted-by":"publisher","first-page":"D886","DOI":"10.1093\/nar\/gky1016","volume":"47","author":"P Rentzsch","year":"2019","unstructured":"Rentzsch P, Witten D, Cooper GM, Shendure J, Kircher M (2019) CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res 47(D1):D886\u2013D894. https:\/\/doi.org\/10.1093\/nar\/gky1016","journal-title":"Nucleic Acids Res"},{"key":"949_CR21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med 17:405\u2013423. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"949_CR22","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/1471-2105-13-134","volume":"13","author":"J Ye","year":"2012","unstructured":"Ye J, Coulouris G, Zaretskaya I, Cutcutache I, Rozen S, Madden TL (2012) Primer-BLAST: A tool to design target-specific primers for polymerase chain reaction. BMC Bioinformatics 13:134. https:\/\/doi.org\/10.1186\/1471-2105-13-134","journal-title":"BMC Bioinformatics"},{"issue":"D1","key":"949_CR23","doi-asserted-by":"publisher","first-page":"D754","DOI":"10.1093\/nar\/gkx1098","volume":"46","author":"DR Zerbino","year":"2018","unstructured":"Zerbino DR, Achuthan P, Akanni W et al (2018) Ensembl 2018. Nucleic Acids Res 46(D1):D754\u2013D761. https:\/\/doi.org\/10.1093\/nar\/gkx1098","journal-title":"Nucleic Acids Res"},{"key":"949_CR24","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","volume":"5","author":"LM de Lau","year":"2006","unstructured":"de Lau LM, Breteler MM (2006) Epidemiology of Parkinson\u2019s disease. Lancet Neurol 5:525\u2013535. https:\/\/doi.org\/10.1016\/S1474-4422(06)70471-9","journal-title":"Lancet Neurol"},{"key":"949_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.14108","volume":"27","author":"R Balestrino","year":"2020","unstructured":"Balestrino R, Schapira AHV (2020) Parkinson disease. Eur J Neurol 27:27\u201342. https:\/\/doi.org\/10.1111\/ene.14108","journal-title":"Eur J Neurol"},{"key":"949_CR26","doi-asserted-by":"publisher","unstructured":"Kestenbaum M, Alcalay RN (2017) Clinical features of LRRK2 carriers with Parkinson\u2019s disease. In: Rideout HJ (ed) Leucine-Rich Repeat Kinase 2 (LRRK2). Springer International Publishing, pp 31\u201348. https:\/\/doi.org\/10.1007\/978-3-319-49969-7_2","DOI":"10.1007\/978-3-319-49969-7_2"},{"key":"949_CR27","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1093\/brain\/awae073","volume":"147","author":"MJ Kmiecik","year":"2024","unstructured":"Kmiecik MJ, Micheletti S, Coker D et al (2024) Genetic analysis and natural history of Parkinson\u2019s disease due to the LRRK2 G2019S variant. Brain 147:1996\u20132008. https:\/\/doi.org\/10.1093\/brain\/awae073","journal-title":"Brain"},{"key":"949_CR28","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1002\/mds.27527","volume":"33","author":"J Trinh","year":"2018","unstructured":"Trinh J, Zeldenrust FMJ, Huang J et al (2018) Genotype-phenotype relations for the Parkinson\u2019s disease genes SNCA, LRRK2, VPS35: MDSGene systematic review. Mov Disord 33:1857\u20131870. https:\/\/doi.org\/10.1002\/mds.27527","journal-title":"Mov Disord"},{"key":"949_CR29","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/mds.29314","volume":"38","author":"SC Parlar","year":"2023","unstructured":"Parlar SC, Grenn FP, Kim JJ, Baluwendraat C, Gan-Or Z (2023) Classification of GBA1 Variants in Parkinson\u2019s Disease: The GBA1-PD Browser. Mov Disord 38:489\u2013495. https:\/\/doi.org\/10.1002\/mds.29314","journal-title":"Mov Disord"},{"key":"949_CR30","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C (2021) Parkinson\u2019s disease. Lancet 397:2284\u20132303. https:\/\/doi.org\/10.1016\/S0140-6736(21)00218-X","journal-title":"Lancet"},{"key":"949_CR31","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1093\/brain\/awae188","volume":"147","author":"A Westenberger","year":"2024","unstructured":"Westenberger A, Skrahina V, Usnich T et al (2024) Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson\u2019s disease study. Brain 147:2652\u20132667. https:\/\/doi.org\/10.1093\/brain\/awae188","journal-title":"Brain"},{"key":"949_CR32","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1093\/brain\/awae142","volume":"147","author":"L Cook","year":"2024","unstructured":"Cook L, Verbrugge J, Schwantes-An TH et al (2024) Parkinson\u2019s disease variant detection and disclosure: PD GENEration, a North American study. Brain 147:2668\u20132679. https:\/\/doi.org\/10.1093\/brain\/awae142","journal-title":"Brain"},{"key":"949_CR33","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2026.1112","author":"A Balck","year":"2026","unstructured":"Balck A, Vollstedt EJ, Westenberger A et al (2026) Genetic testing by age at onset in Parkinson disease. JAMA Neurol. https:\/\/doi.org\/10.1001\/jamaneurol.2026.1112","journal-title":"JAMA Neurol"},{"key":"949_CR34","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/ana.25514","volume":"86","author":"EJ Vollstedt","year":"2019","unstructured":"Vollstedt EJ, Kasten M, Klein C (2019) Using global team science to identify genetic Parkinson\u2019s disease worldwide. Ann Neurol 86:153\u2013157. https:\/\/doi.org\/10.1002\/ana.25514","journal-title":"Ann Neurol"},{"key":"949_CR35","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1093\/brain\/awz191","volume":"142","author":"MMX Tan","year":"2019","unstructured":"Tan MMX, Malek N, Lawton MA et al (2019) Genetic analysis of Mendelian mutations in a large UK population-based Parkinson\u2019s disease study. Brain 142:2828\u20132844. https:\/\/doi.org\/10.1093\/brain\/awz191","journal-title":"Brain"},{"key":"949_CR36","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1002\/mds.25132","volume":"27","author":"LL Kilarski","year":"2012","unstructured":"Kilarski LL, Pearson JP, Newsway V et al (2012) Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson\u2019s disease. Mov Disord 27:1522\u20131529. https:\/\/doi.org\/10.1002\/mds.25132","journal-title":"Mov Disord"},{"key":"949_CR37","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/j.1468-1331.2011.03639.x","volume":"19","author":"E Lohmann","year":"2012","unstructured":"Lohmann E, Dursun B, Lesage S et al (2012) Genetic bases and phenotypes of autosomal recessive Parkinson disease in a Turkish population. Eur J Neurol 19:769\u2013775. https:\/\/doi.org\/10.1111\/j.1468-1331.2011.03639.x","journal-title":"Eur J Neurol"},{"key":"949_CR38","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.1471-4159.2004.02854.x","volume":"92","author":"IH Henn","year":"2005","unstructured":"Henn IH, Gostner JM, Lackner P, Tatzelt J, Winklhofer KF (2005) Pathogenic mutations inactivate parkin by distinct mechanisms. J Neurochem 92:114\u2013122. https:\/\/doi.org\/10.1111\/j.1471-4159.2004.02854.x","journal-title":"J Neurochem"},{"key":"949_CR39","doi-asserted-by":"publisher","first-page":"14162","DOI":"10.1021\/bi7016969","volume":"46","author":"SS Safadi","year":"2007","unstructured":"Safadi SS, Shaw GS (2007) A disease state mutation unfolds the Parkin ubiquitin-like domain. Biochemistry 46:14162\u201314169. https:\/\/doi.org\/10.1021\/bi7016969","journal-title":"Biochemistry"},{"key":"949_CR40","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1212\/WNL.56.4.463","volume":"56","author":"L Terreni","year":"2001","unstructured":"Terreni L, Calabrese E, Calella AM, Forloni G, Mariani C (2001) New mutation (R42P) of the parkin gene in the ubiquitinlike domain associated with parkinsonism. Neurology 56:463\u2013466. https:\/\/doi.org\/10.1212\/WNL.56.4.463","journal-title":"Neurology"},{"key":"949_CR41","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.parkreldis.2009.09.010","volume":"15","author":"JE Ahlskog","year":"2009","unstructured":"Ahlskog JE (2009) Parkin and PINK1 parkinsonism may represent nigral mitochondrial cytopathies distinct from Lewy body Parkinson\u2019s disease. Parkinsonism Relat Disord 15:721\u2013727. https:\/\/doi.org\/10.1016\/j.parkreldis.2009.09.010","journal-title":"Parkinsonism Relat Disord"},{"key":"949_CR42","doi-asserted-by":"publisher","first-page":"597158","DOI":"10.1155\/2013\/597158","volume":"35","author":"KCV Moura","year":"2013","unstructured":"Moura KCV, Campos Junior M, de Rosso ALZ et al (2013) Genetic analysis of PARK2 and PINK1 genes in Brazilian patients with early-onset Parkinson\u2019s disease. Dis Markers 35:597158. https:\/\/doi.org\/10.1155\/2013\/597158","journal-title":"Dis Markers"},{"key":"949_CR43","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1001\/archneur.63.2.273","volume":"63","author":"H Deng","year":"2006","unstructured":"Deng H, Le WD, Hunter CB et al (2006) Heterogeneous phenotype in a family with compound heterozygous Parkin gene mutations. Arch Neurol 63:273\u2013277. https:\/\/doi.org\/10.1001\/archneur.63.2.273","journal-title":"Arch Neurol"},{"key":"949_CR44","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/mds.22365","volume":"24","author":"ST Camargos","year":"2009","unstructured":"Camargos ST, Dornas LO, Momeni P et al (2009) Familial Parkinsonism and early onset Parkinson\u2019s disease in a Brazilian movement disorders clinic: Phenotypic characterization and frequency of SNCA, PRKN, PINK1, and LRRK2 mutations. Mov Disord 24:662\u2013666. https:\/\/doi.org\/10.1002\/mds.22365","journal-title":"Mov Disord"},{"key":"949_CR45","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1093\/brain\/awab456","volume":"145","author":"W Zhu","year":"2022","unstructured":"Zhu W, Huang X, Yoon E et al (2022) Heterozygous PRKN mutations are common but do not increase the risk of Parkinson\u2019s disease. Brain 145:2077\u20132091. https:\/\/doi.org\/10.1093\/brain\/awab456","journal-title":"Brain"},{"key":"949_CR46","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/mds.10601","volume":"18","author":"SJ Lincoln","year":"2003","unstructured":"Lincoln SJ, Maraganore DM, Lesnick TG et al (2003) Parkin variants in North American Parkinson\u2019s disease: Cases and controls. Mov Disord 18:1306\u20131311. https:\/\/doi.org\/10.1002\/mds.10601","journal-title":"Mov Disord"},{"key":"949_CR47","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/ana.21039","volume":"61","author":"DM Kay","year":"2007","unstructured":"Kay DM, Moran D, Moses L et al (2007) Heterozygous parkin point mutations are as common in control subjects as in Parkinson\u2019s patients. Ann Neurol 61:47\u201354. https:\/\/doi.org\/10.1002\/ana.21039","journal-title":"Ann Neurol"},{"key":"949_CR48","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/ana.27155","volume":"97","author":"K Daida","year":"2025","unstructured":"Daida K, Yoshino H, Malik L et al (2025) The utility of long-read sequencing in diagnosing early onset Parkinson\u2019s disease. Ann Neurol 97:753\u2013765. https:\/\/doi.org\/10.1002\/ana.27155","journal-title":"Ann Neurol"},{"key":"949_CR49","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0022-2836(02)01376-1","volume":"326","author":"AB West","year":"2003","unstructured":"West AB, Lockhart PJ, O\u2019Farell C, Farrer MJ (2003) Identification of a novel gene linked to Parkin via a Bi-directional promoter. J Mol Biol 326:11\u201319. https:\/\/doi.org\/10.1016\/S0022-2836(02)01376-1","journal-title":"J Mol Biol"},{"key":"949_CR50","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/humu.20436","volume":"28","author":"S Lesage","year":"2007","unstructured":"Lesage S, Magali P, Lohmann E et al (2007) Deletion of the parkin and PACRG gene promoter in early-onset parkinsonism. Hum Mutat 28:27\u201332. https:\/\/doi.org\/10.1002\/humu.20436","journal-title":"Hum Mutat"},{"key":"949_CR51","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1056\/NEJM200005253422103","volume":"342","author":"CB L\u00fccking","year":"2000","unstructured":"L\u00fccking CB, D\u00fcrr A, Bonifati V et al (2000) Association between early-onset Parkinson\u2019s disease and mutations in the Parkin gene. N Engl J Med 342:1560\u20131567. https:\/\/doi.org\/10.1056\/NEJM200005253422103","journal-title":"N Engl J Med"}],"container-title":["Neurogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-026-00949-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10048-026-00949-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-026-00949-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:30:52Z","timestamp":1791271852000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10048-026-00949-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["949"],"URL":"https:\/\/doi.org\/10.1007\/s10048-026-00949-5","relation":{},"ISSN":["1364-6753"],"issn-type":[{"value":"1364-6753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"assertion":[{"value":"14 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written informed consent was obtained from all individual participants included in the study or, where applicable, from their legal representatives.","order":1,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"79"}}